Upcoming Events

Meet us in person!

Here you can find a list of all upcoming events.


Stay updated!

Your name*

Your email-adress*

I agree that the company CorTec GmbH may contact me to inform me on selected topics
(News and interesting stories about the Company, Product information, new product developments, Events).
My data is used exclusively for this purpose. In particular, no disclosure to unauthorized third parties.
I am aware that I can revoke my consent at any time with effect for the future.
I can do this via the following channels: electronically via an unsubscribe link in the respective newsletter, by e-mail to: or by post to: CorTec GmbH, Neuer Messplatz 3, 79108 Freiburg, Germany.
The privacy policy of the company CorTec GmbH applies, which also contains further information about possibilities for correction, deletion and blocking of my data.

Dr. Harald Poth, Marco Winzer and Prof. Dr. Pascal Fries new members of CorTecs Advisory Board

Following the conclusion of a new round of investments last fall, CorTec is now expanding the expertise in the two advisory boards of the medical technology company. Dr. Harald Poth from LBBW Venture Capital GmbH joins the company’s Advisory Board together with Marco Winzer from High-Tech GrĂŒnderfonds (HTGF), who is replacing Mr. Bernhard Meder. Prof. Dr. Pascal Fries from the Ernst StrĂŒngmann Institute for Neuroscience was appointed to the Scientific-Technical Advisory Board of CorTec.


For the third time in a row CorTec is ranked among the most innovative companies in Germany. Statista has been conducting out the survey since 2014 and has joined forces with German business magazine Capital for the first time this year for the award. Together with 14 other companies in the medical devices industry, CorTec is entitled to carry the title “Germany’s Most Innovative Company” in this segment.


Dear customers, partners and friends,

just like you, we at CorTec are currently under the strong influence of COVID-19. However, we can still maintain our operations and continue to be there for you.

With this letter we would like to inform you about how we are currently working and how you can reach us.


The MD&M West is the world’s largest medical design and manufacturing event. From 11th to 13th February 2020 more than 1,900 suppliers and more than 20,000 professionals will come together in the Anaheim Convention Center. We will be present with our products at booth #3071.

Use the promo code SPECIAL for a free expo pass and 20% off conference passes.

Learn more about MD&M West.

As you know, we can produce electrodes in very fine structures tailored to the requirements of your application. To support you handling such delicate structures we have produced a short video tutorial on how to unbox your electrode.

Check out the video

The International BCI Award, endowed with 6,000 USD, is one of the top accolades in BCI research.
The BCI Award was created to recognize outstanding and innovative research in the field of Brain-Computer Interfaces. CorTec proudly encourages this award in 2020.


12 projects are nominated before the winner is announced at the BCI Award Ceremony which takes place at the 8th International BCI Meeting 2020 in Brussels (Belgium).

Use your chance and submit your project until April 1st, 2020!


Download the BCI Award Flyer or visit the official website for more detailed information.

Dear customers, partners and friends,

for the second time our new building takes a break from us for the holiday season.

A very exciting year with the clearance of our first medical device in the USA, a series of awards, a newly closed funding round and many interesting encounters with all of you is drawing to a close.

The CorTec office has already prepared for the holiday season. Click here to see the animated GIF.

We wish you happy holidays and a good turn of the year and will be there for you and your projects again in the new year!

Merry Christmas & a Happy New Year!

Your CorTec team

Today CorTec announced the close of a €13 million funding. The investor consortium is led by Santo Venture Capital, the StrĂŒngmann family holding company. Alongside LBBW Venture Capital, several existing shareholders participate in the funding round. Based on the investments, CorTec plans the next step of expansion with a subsidiary in the USA and the development of the next generation of the Brain Interchange Technology.


In research, the closed-loop approach is regarded as a promising method for achieving further progress in neurotherapy. CorTec launches a series of articles presenting the research and development of therapies based on closed loop, previous successes as well as upcoming challenges.

Closed loop means an adaptation of the therapeutic stimulation to the acute treatment needs of the patient. According to recent research results, existing neurotherapies, for example for Parkinson’s disease, can benefit from an adaptive treatment approach just as much as new therapies can become possible.

Learn about the background of the closed-loop approach

As every year we are exhibiting at the world’s largest neuroscience meeting organized by the Society for Neuroscience which is held in in Chicago this year.

We are presenting new electrode designs alongside our well-known products for recording and stimulation in the central as well as in the peripheral nervous system. Visit us at booth no. 1642 to also get the latest update on our Brain Interchange ONE closed-loop implant system.

Learn more about the SfN meeting

We have created a completely new section on our website where we give you a comprehensive insight into our daily work, innovations in our products and technologies as well as into interesting facts about CorTec.

In regular intervals we are going to publish new articles, photos and videos there and we hope that you will enjoy following the history of our further development.

Check out the first stories that are already published and come back soon to find some more..

On the evening of 28 June 2019, CEO, Dr. Jörn Rickert and Dr. Christina Schwartz received CorTec’s “TOP 100” award at the Jahrhunderthalle in Frankfurt. CorTec was ranked among the 10 best companies.

For the 26th time, the most innovative companies in Germany were honoured. On the basis of scientific systematics, TOP 100 evaluates the innovation management of medium-sized companies.


We are very pleased about the award and the confidence in our innovative strength.

Special thanks go to our strong team for the outstanding achievements that made this award possible.


Find out more about TOP 100 and the selection process here.

As one of five companies, CorTec was awarded the Freiburg Innovation Prize by the Technology Foundation Bio-Med Freiburg.

Bio-Med Freiburg has been awarding the prize every two years since 1992 in cooperation with the medical technology company Stryker and the bank Sparkasse Freiburg-Nördlicher Breisgau. The companies that received the award in this year’s edition are active in the fields of medical technology, chemistry, software and green energy.

The °AirRay Cortical Electrode is CorTec’s first medical device to receive market clearance from the Food and Drug Administration (FDA) in the USA for invasive neuromonitoring in the central nervous system. It can now be used as a diagnostic aid, for example before brain surgery.

“For us as a company, the market clearance of our AirRay electrodes is an important milestone,” said Dr. Jörn Rickert, Chief Executive Officer of CorTec. “lt shows to us and to our customers that we have been working in the right direction. Together with our new premises, including our own production facility we are now ideally positioned as a partner for the development of innovative neurotherapies.”

Some brain diseases may require surgical resection of the affected parts of the brain. AirRay Cortical Electrode is used for invasive neuromonitoring which comprises recording and stimulation of brain activity from the cortical surface over a period of time. In order to precisely locate diseased brain tissue such as epileptogenic foci or brain tumors while protecting healthy areas responsible for important brain functions, the brain must be ‘mapped’ prior to surgery. The electrode may be used for up to 29 days.

CorTec introduces several innovations into this long-established method of treatment. The planar grid and strip electrodes are produced in a proprietary laser-assisted manufacturing process. This results in a very soft, thin, and flexible electrode that adapts well to the curved surface of the brain.

In combination with new analytical methods AirRay Cortical Electrode may enable shorter surgery durations and more precise diagnostics in the future: For example with the aid of automated mapping of the brain in real-time, as enabled by the CortiQ system from g.tec (Austria), it will be possible to locate functional brain areas faster and more reliably in the future.  A research group led by Nuri F. lnce at the University of Houston, Texas, is investigating high-frequency oscillations in brain activity as biomarkers for a more precise determination of epileptogenic foci. “Regulatory approval of CorTec’s AirRay Cortical Electrode opens up exciting new options both in clinical applications and in research using intracranial recording and stimulation methods,” commented neuroscientist Dr. Gerwin Schalk, Chair of the International Workshop on Advances in Electrocorticography series and Deputy Director of the National Center for Adaptive Neurotechnologies in Albany.

The product also contains important safety features. “Health and well-being of the patient are of the utmost importance to us. Therefore, we emphasize safe electrode design,” said Dr. Martin SchĂŒttler, Chief Technology Officer and also Chief Executive Officer of CorTec. °AirRay Cortical Electrode has an even surface with individual electrode contacts almost being impalpable. Additionally, to prevent the contacts from dislocating or detaching from the silicone carrier material each contact safely interlocks with the material.

CorTec plans to market the AirRay Cortical Electrode through distribution partners. Corresponding contracts are currently in preparation.

Learn more about °AirRay Cortical Electrode

Download the press release on the market clearance of °AirRay Cortical Electrode


[1] See the publication by S. Liu et al., Brain 2018, 1, doi:10.1093/brain/awx374

Meet us at the 9th International IEEE EMBS Conference on Neural Engineering focussing on “Neurotechnologies for Medical Therapies and Beyond” taking place from March 20-23 in San Francisco.
CTO and CEO, Dr. Martin SchĂŒttler, will give a talk about ‘Focus on Neural interface and Electrode Technologies’ at the IEEE NeuroTech Entrepreneurship and Innovation Workshop on March 20th during Symposium#2: Neural Probes, Interface and Electrode, Orthopedics Technologies between 11am and 12:30pm.

Just like last year CorTec has made it to the list of the most innovative companies selected by German business journal brand eins and Statista. Together with 16 other companies in the medical devices industry CorTec may now bear the title “Innovator 2019”.

Experts from the Institute for Innovation an Technology (iit) in Berlin and from the Statista panel „Expert Circle“ as well as leading business representatives from innovation award-winning companies have assessed more than 2,000 companies from 20 industries this year. Other companies in the “Medical Devices and Products” / “Medizinische GerĂ€te und Produkte” industry that are acclaimed alongside CorTec are for example Otto Bock Healthcare, Medtronic, Siemens Healthcare, Heraeus or Med-El.

“The renewed distinction as one of the most innovative companies is a great honor for us, especially as it reflects the consistency in our development as a company over the last years,” said Dr. Jörn Rickert, Chief Executive Officer of CorTec. “After moving to our new facilities and bringing the human version of our Brain Interchange system into operation we still see high potential to boost our innovative capabilities,” added Dr. Martin SchĂŒttler, Chief Technology Officer and Chief Executive Officer of CorTec. “We are just at the beginning.”

CorTec is positioning itself with its Brain Interchange technology as a partner for the development of innovative neurotherapies. First customers are using the closed-loop system already for pre-clinical research. The first human use of the system for exploring new personalized therapies for diseases like chronic pain, stroke, or Parkinson’s disease is about to follow as soon as possible.

CorTec is partnering up with researchers, clinicians, or other companies providing knowhow and technology to enable the development of next generation neuortherapies.

Learn more about the most innovative companies in Germany

Learn more about CorTec Brain Interchange

The annual meeting of the North American Neuromodulation Society (NANS) starts today in Las Vegas focussing on “The Science Behind Successful Outcomes.”

CorTec will be represented with a poster. Check out the poster monitors to learn more about our AirRay electrode technology as well as about CorTec Brain Interchange, our closed loop implant system.

Learn more about NANS

We have started operations in our new offices in August. By the end of the year also our new manufacturing facility has been complete.

We are now in the process of qualifying the cleanroom. In the course of this process the first electrode has just been produced. A lot more are about to come…

The CorTec deer has already prepared for the holiday season.

We are taking a short break, but will be back at the beginning of the new year to support you and your projects also in 2019.

We hope you are going to have some sparkling holidays just like our deer.

Merry Christmas & a Happy New Year!

As every year, we are exhibiting at the annual meeting of the Society for Neuroscience which takes place from November 4-7 at the San Diego Convention Center this year. Visit us at booth no. 3816.

Prior to the conference you already have the chance to meet us on November 1 and 2 at the IEEE Brain Initiative Workshop on Advanced NeuroTechnologies at the Hilton Bayfront Hotel in San Diego.

From November 12-15 we are the Compamed in DĂŒsseldorf, Germany. We are happy to welcome you at booth no. H29.1 in hall 8a.

We are happy to make an appointment with you in advance. Please call us (+49 761 70 888 222) or send us an email ( to arrange the appointment.

As active implants are dynamically spreading, also the requirements towards their MRI compatibility are increasing constantly. In the framework of the new funding project MR-Implant CorTec is developing new solutions for MRI compatible implants together with the Universtiy of Ulm, the Max Planck Institute for Biological Cybernetics and the company eesy-ic as project partners.

More and more patients receive active implants like cardiac pacemakers, neurostimulators, medication pumps etc. while MRI examinations are becoming the medical standard procedure for an increasing number of indications. At the same time most of the active implants are not or only with strong limitations MRI compatible.

With its Smart Health Initiative the German Federal Ministry of Education and Research (Bundesministerium fĂŒr Bildung und Forschung, BMBF) faces the challenge to promote innovations in the filed of medical engineering which meet the requirements of patients and medical care systems in the future. The funding program supports the MR-Implant consortium until the year of 2021 to develop new solutions for the MRI compatibility of active implants.

The project which is coordinated by CorTec aims at developing active implant systems which are able to exchange data at high speed, to record as well as to stimulate neural activity while enabling interference-free MRI examinations at the same point in time. The measured data of the implant can then be compared with the results of MRI examination. This way a more precise calibration of the implant system shall be possible as well as an improved therapy which adapts to the momentary needs of the individual patient.

“The possibility to conduct MRI examinations while the implant is operating is extremely advantageous in clinical practice,” said Prof. Dr. Ulf Ziemann, chairman of the Department of Neurology and Stroke at University Hospital TĂŒbingen and member of CorTec’s Scientific Technical Advisory Board. “Being able to precisely locate electrical brain signals enables us to synchronize the placement of the implant with the individual patient’s anatomy. Based on these data we can determine the coordinates of measuring and stimulation accurately so that finally we can implement patient-individual therapy.”

CorTec’s Brain Interchange technology will implement the results of the joint project. The closed-loop implant system can record and stimulate in long-term application. Thus, it enables communication between the nervous system and artificial intelligence – the starting point for the development of innovative personalized therapies.


Learn more about the MR-Implant project

Learn more about CorTec’s Brain Interchange System

On October 18 CorTec has opened its new headquarters at Freiburg fairground with an official ceremony.

The greetings from the mayor of Freiburg, Martin Horn, the medical director of the University Hospital of Freiburg, Prof. Dr. Jörg RĂŒdiger Siewert, the Vice Rector of the University of Freiburg, Prof. Dr. Gunther Neuhaus as well as from the chairman of the Advisory Board of CorTec Prof. Dr. Klaus Mangold, represented by Dr. Christoph Mangold were followed by a keynote from Prof. Dr. Niels Birbaumer. The pioneer in researching Brain Computer Interfaces as an assistive device for severely paralyzed people gave an insight into the current status of the technology, previous successes, and future challenges.

After the ceremony the guests had the opportunity to visit the new premises and to learn more about the company and its technology.

Dear customers, partners and friends, on Friday August 24 we are moving into our new premises close to Freiburg fairground.

There we are going to have 400 squaremeters of cleanroom and laboratory facilities together with 1,000 squaremeter of office space where we can develop and produce the next generation of implants for communication with the brain and the nervous system.

We apologize for any inconvience regarding our availabilities during the move!

We are partnering up with researchers towards innovative neurotherapies: CorTec is listed as industry partner for SPARC Program and BRAIN Initiative!

With SPARC Program and BRAIN Initiative the National Institutes of Health (NIH) have launched two important funding programs for innovative research that shall support the development of the next generation of neurotechnology and neurotherapies.

Both funding programs have established a network of industry partners who are offering their technology for neuromodulation applications. CorTec is now listed as partner for researchers funded by SPARC and BRAIN providing solutions like flat or cuff electrodes, encapsulation technology or the Brain Interchange system for closed-loop interaction with the neural system.

Both, SPARC Program and BRAIN Initiative are funding exciting research like for example the interdisciplinary project led by Edward Chang at the University of California, San Francisco which aims at decoding the functional architecture of the speech motor cortex.

“Step by step Dr. Chang’s research builds the fundamentals for eventually reading the words unspoken by patients suffering from paralysis”, commented CorTec CEO Dr. Joern Rickert. “Already five years ago he demonstrated in a study in collaboration with Robert Knight that is possible to understand simple sentences from the spectrograms reconstructed from ECoG recordings (Pasley et al. 2012). Now he is taking this work to the next level.”

Another project which also aims at understanding the production of language runs in collaboration between Nitin Tandon and Nathan Crone at the University of Texas and Johns Hopkins University: Using closed-loop direct cortical stimulation they want to modulate brain activity at identified nodes to provide insight into language processing inside the brain.

Closed-loop interaction with the nervous system is constantly gaining ground in top-level research.

Two projects are focusing on improved therapies of Movement disorders (Parkinson’s disease and essential tremor) based on closed-loop stimulation. While the project led by Philip Starr at the University of California, San Francisco addresses the detection of brain signals to the parameters of stimulation in the closed loop Aysegul Gunduz’s project at the University of Florida focuses on Essential Tremor. Due to the intermittent appearance of these symptoms continuous stimulation is likely unnecessary and could cause side effects that might be eliminated by introducing a closed-loop therapy.

“As to this moment we cannot be certain if side effects of continuous stimulation can be improved by ‘closing the loop’ and changing to adaptive stimulation patterns”, pointed out Prof. Dr. Volker A. Coenen, member of the Scientific Technical Advisory Board of CorTec. “Especially Essential tremor, which typically is treated with bilateral DBS, might cause speech and gait disturbances elicited by co-activation of the cerebellum [Reich MM et al. Brain. 2016]. It is hard to understand why essential tremor is regarded as fluctuating since it typically is not (much unlike Parkinson’s disease). It might however be meaningful to reduce stimulation during tasks that do not require optimal tremor control. Never the less it is intuitive to try and ameliorate these effects by changing from continuous to adaptive stimulation technology. The two groups mentioned are certainly at the forefront of this DBS research.”


Learn more about SPARC and download the CorTec device information

Learn more about BRAIN Initiative and download the CorTec device information

German technical Magazine Design & Elektronik has nominated CorTec among other 8 companies in the field of medical engineering (Medizintechnik) for the election of the “Innovator of the Year”.

The Design & Elektronik editors give the following explanation for nominating CorTec: In majority of cases neuro-implants are used for patients with an increased co-morbidity who have to undergo MRI examinations. Most systems on the market do not address the requirement of MRI compatibility at all or do not address it sufficiently. CorTec is working on an active implant for long-term application which is MRI compatible.

Vote for us until August 31!

Learn more about our MR-Implant project

The latest issue of German technical magazine Medizin & Technik summarises the results of this year’s Compamed Spring Forum which had a focus on active implants: The large challenges which implant manufacturers have to address today are miniaturisation and digitalisiation.

At the conference whcih took place at the beginning of May in Frankfurt Dr. Martin SchĂŒttler, CTO and CEO at CorTec, presented the CorTec Brain Interchange system which enables communication between the nervous system and artificial intelligence. Other projects were introduces by companies like Osypka, Comelec oder Specialty Coating Systems.

Read the article (in German)

German Newspaper Badische Zeitung has published a detailed portrait of CorTec in the business section of the Saturday edition which talks about technology, development goals and history of the company.

Read the Article (in German)

The discussion about the influence of intelligent implants and artificial intelligence on humans has been creating more and more interest beyond scientific circles or the media. The technological progress can create unimagined possibilities of technical support to humans in the future as well as minor or major risks which are difficult to predict.

CorTec is ready to take a position at the center of the discussion. As manufacturer of intelligent implant technology the evaluation of risks over technological advantages is part of our day-to-day business.

CorTec stellt sich ins Zentrum dieser Diskussion. Als Hersteller von Intelligenter Implantat-Technologie gehört das AbwĂ€gen von Risiken gegenĂŒber technologischen Vorteilen fĂŒr uns zum tĂ€glichen GeschĂ€ft.

At a panel discussion organized by the New Digital Business Unit of Deutschen Bahn on May 8 in Berlin CorTec Ceo Dr. Jörn Rickert will discuss thinkable variations of the future development together with Prof. Dr. Paul Lukowicz and Prof. Dr. Wolfgang Maaß from the German Research Center for Artificial Intelligence (Deutsches Forschungszentrum fĂŒr KĂŒnstliche Intelligenz, DFKI) and cyborg and publicist Enno Park.

More information about the event

In an interview with Ladan Jiracek for the Neural Implant Podcast our CEO Dr. Jörn Rickert introduces CorTec’s technology and the options to develop innovative neurotherapies offered by it. In the second part of the interview they also discuss ethical questions which are related to the use of artificial intelligence to control therapies.

The interview was recorded during the last Neuroscience Meetings in Washington DC. The Neural Implant Podcast has recently launched a YouTube Channel so it is now available also in a video version.



Learn more about CorTec Brain Interchange Technology

Learn more about Neural Implant Podcast

A high number of chronic diseases is influenced by the nervous system. Activating or blocking peripheral nerves affects a lot of physiological functions – an effect that can be utilized for therapeutic treatment. At the Bioelectronic Medicine Forum in New York brings together scientific and practical experts who will discuss the present status in the development of new therapies in this field.

Electrical stimulation of nerves as a therapeutic way to treat diseases is an attractive alternative to pharmaceuticals which in many cases cannot help or cannot help any more. This option gets even more interesting especially because the development of new pharmaceuticals has stagnated in the past years.

Bioelectronic medicine can address many medical problems which could not be treated in a sufficient way so far like or example chronic and acute inflammatory diseases such as Crohn’s disease, rheumatoid arthritis or Lupus. Latest scientific findings increasingly indicate a positive therapeutic influence of bioelectronic therapies on clinical pictures like diabetes, hypertension, paralyses or maybe even cancer.

The Bioelectronic Medicine Forum is organized by Neurotech Reports with support of the Feinstein Institute. At the conference taking place on Thursday, March 22, at the Millenium Broadway Hotel CEO Dr. Jörn Rickert is presenting CorTec’s work on interfaces to the peripheral nervous system.

Learn more about the Bioelectronic Medicine Forum

Learn more about Bioelectronic Medicine

Learn more about CorTec’s interfaces to the peripheral nervous system

German business journal brand eins has just published a study in cooperation with Statista which selects CorTec among 15 other companies “Innovator 2018” in the medical devices industry.

Experts from the Institute for Innovation an Technology (iit) in Berlin and from the Statista panel „Expert Circle“ as well as leading business representatives from innovation award-winning companies have assessed more than 3,400 companies from 20 industries. The criteria of the assessment focused on the innovative capabilities of these companies regarding their products and services, their processes as well as their corporate culture.

Other companies in the “Medical Devices and Products” / “Medizinische GerĂ€te und Produkte” industry that are acclaimed alongside CorTec are for example Otto Bock Healthcare, Medtronic, Biotronik, Brainlab or Med-El.

Learn more about the most innovative companies in Germany



CorTec is featured with a detailed portrait in the January issue of Neurotech Business Reports. The article introduces the company, its products and services, as well as future plans.

Read the full Business Report here: NeurotechReports_CorTec_January2018

Learn more about Neurotech Reports and stay updated on innovations in the neurotechnology sector.

We had a great start at MD&M West. Until Thursday, February 08, you can find us at booth no. 2974. Check out our products and services!

Also this year we are exhibiting at MD&M West in Anaheim from February 06 to 08. For the first time a matchmaking is offered where attendees have the chance to meet exhibitors for discussing potential joint projects.

We are presenting our products and services for industry customers at the biggest medical supply trade fair in North America: from complete systems for closed-loop interaction with the human brain to custom-designed electrodes, hermetic encapsulations, and combined services like electronics or software development.

Visit us at booth no. 2974!

We are happy to make an appointment with you in advance. Contact us through or the matchmaking portal of MD&M West.

Learn more about MD&M West


On February 8 at 17h CET / 11 a.m. EST we are hosting the webinar “Utilizing Nerve Cuffs for in vivo Peripheral Nerve Research” on Inside Scientific.

Experts like Dr. TĂ©a Tsaava from the Feinstein Institute, New York,  Christopher Langdale from Duke University, Durham, and CorTec CTO Dr. Martin SchĂŒttler discuss novel cuff electrodes for in vivo peripheral nerve research, including the importance of electrode design, how to select the right cuff, implantation techniques and application results from nerve stimulation and blocking.

Learn more about the webinar

Register now!

CorTec and the Wyss Center, a non-profit neurotechnology translation organization, have signed a partnership agreement. They will collaborate in developing a novel, minimally invasive brain monitoring and stimulation device.

The partners will work together on research, design and development of a device for continuous, long-term, monitoring of the brain’s electrophysiological signals for clinical diagnostic and therapeutic applications.

The planned device based on CorTec’s Brain Interchange technology will sit on the skull, beneath the skin and has potential uses in epilepsy monitoring, tinnitus regulation through neurofeedback, neuromodulation for dyslexia and other brain circuit disorders.

The terms of the agreement include the fabrication of novel subcutaneous brain stimulation and monitoring electrodes. The collaboration provides the Wyss Center with exclusive access to novel technology from CorTec for subcutaneous neuromodulation solutions in many promising new applications.

Copyright: Wyss Center

Suitable for long-term implantation, the CorTec Brain Interchange system is an implantable brain stimulation and recording device that allows for chronic closed loop interaction with the brain. The multi-channel system consists of an implanted unit comprising neural electrodes and an electronic unit which both digitizes neural signals and sends stimulation impulses to the neural tissue via the electrodes. It communicates wirelessly with a body-external telemetry unit which is also responsible for power supply. The telemetry unit communicates with a computer that controls the application autonomously based on the recorded data and enables a needs-oriented therapy.

Professor John Donoghue, Director of the Wyss Center said: “Our partnership with CorTec could result in far reaching benefits for many neurotech device development projects underway today. CorTec’s existing technologies, along with their enthusiastic approach to research and innovation, makes them an ideal partner for the Wyss Center. We are looking forward to working together to help people with nervous system disorders regain their independence.”

“At the Wyss Center we are developing a minimally invasive device for the chronic recording of global brain signals. The system will also be capable of electrical stimulation, for diagnostic and therapeutic applications.” said George Kouvas, Programme Manager. “The collaboration with CorTec will accelerate this development and enable us to progress to clinical trials more quickly for the benefit of people with brain circuit disorders.”

“In a very short time the Wyss Center has built impressive facilities and a highly skilled team heading with verve for innovative personalized neurotherapies. We are looking forward to working with John Donoghue and the people at the Wyss Center to realize novel therapies,” commented CorTec CEO Joern Rickert, Ph.D., on the collaboration.

Martin Schuettler, Ph.D., CTO and CEO at CorTec added: “Until now many innovative therapy approaches could not be developed because suitable technology was lacking. Together with the Wyss Center we can close this gap based on our Brain Interchange system while at the same time pushing the boundaries of our current technology by exploring new methods and materials.”

Further development and optimization of existing minimally invasive long-term monitoring devices has the potential to accelerate multiple neurotechnology applications and could revolutionize the diagnosis and treatment of neurodisorders.

Learn more about epilepsy treatment and the Wyss Center.

Download the full press release: CorTec_PressRelease_01-2018

This year we are visiting the 21st Annual Meeting of the North American Neuromodulation Society from 11th – 12th January in Las Vegas.

Listen to our talk in the ‘Next Generation Brain Devices’  Session:
Dr. Fabian Kohler: ‘An Implantable Brain‐Computer Interface for Investigation of Closed‐Loop Therapies’, ePoster Presentation
– Saturday 13 January, 7:15-7:25 at Caesars Palace Convention Center

For questions please reach out to



As every year we are exhibiting at the annual meeting of the Society for Neuroscience and at Compamed.


We are looking forward to welcome you at

booth no. 828 at Neuroscience at Walter E. Washington Convention Center in Washington DC, USA


booth no. H29.1 at Compamed in hall 8a at Messe DĂŒsseldorf!


In Washington DC you can also meet us at the following pre-events to Neuroscience:

  • IEEE Brain Initiative Workshop at NAHB
  • Workshop on Advances in Electrocorticography at Renaissance Downtown Hotel


Please contact us, if you would like to fix a meeting date with us in advance:

+49 (0)761 897694520


For the first time an intervention based on tailor-made electrodes from CorTec was performed at the University Hospital of Goethe University in Frankfurt: The seven-year-old girl with epilepsy is seizure-free since the surgery.

Epilepsy is an extremely devastating disease, in particular in children like seven-year-old Nora. Until now her day was dominated by up to 30 epileptic seizures which were so strong that she would frequently become unconscious and fall over on such an event. Since the seizures were completely unpredictable and could attack the little girl all of a sudden at any time Nora had to be monitored around the clock such that somebody could immediately succor her and to prevent her from injuring herself when a seizure would strike.

A normal child’s life with going to kindergarten and school or just playing with friends was impossible for Nora. The disease also strongly inhibited her physical and mental development. Currently available drugs did not offer sufficient relief to Nora – as is the case for roughly one third of all epilepsy patients in general.

Thanks to a new technology Nora finally got help at the Center of Neurology and Neurosurgery (CNN) at University Hospital Frankfurt.  A custom-made electrode grid from CorTec supported the pre-operative diagnostics intended to identify the brain tissue that was involved in generating the epileptic seizures and that was supposed to be removed afterwards. A high number of electrode contacts covered the affected brain areas precisely. This enabled an optimal localization of the diseased tissue and healthy areas that should be preserved as best as possible during surgery.

Dr. Martin SchĂŒttler, chief technology officer at CorTec, explains how this new type of electrode grids is produced: “Based on individual MR images from the brain of the patient we tailored the electrode for her according to the requirements of the University Hospital. The innovative laser-aided manufacturing technology that we use at CorTec allows the production of very soft and thin contact mats which thanks to their flexibility adapt to the curved surface of the brain.”

For several days Nora’s brain was ‘mapped’ in detail to identify healthy and diseased brain regions exactly. During a five-hour surgery afterwards at CNN neurosurgeon Dr. Thomas Freiman was able to precisely remove the problematic region.


“The remarkable softness and flexibility of the CorTec electrode as well as its individual tailoring to the patient have been extremely valuable for the particularly difficult surgery that we had to perform on this child,” says Freiman. “The electrode proved to be very gentle and tissue-friendly. Even after 10 days of implantation it was still exceptionally well tolerated by the body. We did not observe any undesirable but frequent side effects such as bleeding”.

The surgical procedure was remarkably successful. From the day of surgery Nora has been seizure-free, something that has not happened ever since the onset of the disease. Now she is looking forward to a six-month rehabilitation period during which she will recover at her own pace and catch up on important development steps. All results indicate that the surgery has successfully overcome the disease with the help of latest technology. To the small patient new prospects are opening up on a normal life as a child and later also as an adult.



Learn more about epilepsy treatment at the Center of Neurology and Neurosurgery at University Hospital Frankfurt

Download the full press release: CorTec_PressRelease_03-2017

Meet our CTO Dr. Martin SchĂŒttler at the Annual Meeting of the Biomedical Techniques in Dresden!

On Montay, 11.09.2017, from 4.45 to 5.15pm he is giving a talk in Session about “Nerve cuff electrodes for electrically interfacing with the peripheral nervous system“.

The Session titeled “Bioelectronic Medicine / Electroceuticals” is chaired by Prof. Thomas Stieglitz, member of the Scientific Technical Advisory Board of CorTec.

More Information about the conference

CorTec_BrainInterchange_SurfaceAndDepthElectrodeA few days ago a new paper about Brain Computer Interfaces has bee published to which CorTec has contributed in cooperation with scientific partners. The study examines the performance of BCIs including CorTec Brain Interchange with regard to the requirements of new therapies.

The researcher group comes to an important conclusion: No technology which is currently on the market is powerful enough to realize effective closed loop applications which are urgently needed to develop therapeutic innovations. In the closed loop the implant controls itself autonomously by using the recorded data that it collects after sending out stimulation impulses

CorTec Brain Interchange could be a game changer to realize such applications.

Zum Paper

Learn more about CorTec Brain Interchange


CorTec is proud to support this year’s summer course at the National Center for Adaptive Neurotechnologies! During the last weeks the next generation of top-level researchers has been studying and working on new approaches in neuroscience, engineering, computer science, and signal processing.

Follow our CEO Dr. Jörn Rickert in the video livestream of his talk introducing CorTec’s Brain Interchange closed-loop technology on Friday, July 28 at 9am EDT / 3pm CET (registration required)!

We are proudly presenting to you our new White Paper on nerve cuff electrodes. It represents a basic guideline for working with cuff electrodes in the peripheral nervous system.

Whitepaper_Title_ThumbnailThe White Paper gives you an overview about

  • the important factors for selecting the right electrodes,
  • the preparation of the electrode before implantation,
  • the basic conditions of a successful implantation as well as about
  • the use of cuff electrodes in your experiment.

CorTec is producing a variety of cuff electrodes made of minimal traumatic flexible silicone with various closure mechanisms.

AirRay research Micro Cuff Tunnel and AirRay research Micro Cuff Sling form our standard product portfolio available for applications in pre-clinical research.

The Standard configurations start at 100”m of inner diameter with 2mm of electrode length going up to inner diameters of several millimeters. Individual contact configurations and other customized specifications are also available.

Download the White Paper


As CorTec products are getting more and more popular, we started to collect the publications in which our products are involved to give you some deeper insights into the performance of our products at a glance.

We also would like to introduce you to some of our customers who share their experience of working with different products of ours with the community.

Check out our References

In the course of this year the young medical technology company is going to establish a new facility, including a manufacturing site, in Freiburg, Germany. Since its founding in the year 2010, CorTec GmbH has brought innovative products and technologies to the market. The company underlines its perspective of continuous growth by moving to a significantly larger location.

Currently, CorTec is located at the campus of the Faculty of Engineering of the University of Freiburg. The company sees increasing interest in its high-quality products and components for neurotherapeutic applications. In the course of the last years CorTec has established itself as a partner and supplier of an international circle of industry clients in this field. This success is now reflected in the expansion to the new location. “We have achieved a lot in the recent years. Therefore, we are delighted that the success and growth of the company now also enters the expansion,” managing directors Dr. Jörn Rickert and Dr. Martin SchĂŒttler said.

With more than 3,500 square feet the new production areas will increase the production capabilities from thousands to ten thousands of products per year. Additionally the new location offers space for a fast increase from the current staff of 36 people working in the departments development, manufacturing, quality management and administration to around 60 employees.


Floor plan of the first company headquarters of CorTec GmbH


CorTec develops and manufactures high-quality components of neurotechnological implants. CorTec’s products are characterized by high precision, high flexibility in design, and can contain high numbers of channels – features which enable personalized therapies for neurological diseases. The °AirRay electrode technology based on a laser-aided process offers high-data acquisition as well as stimulation in the central and peripheral nervous system. The innovative hermetic ceramics encapsulation is optimized for a uniquely high number of feedthroughs, battery-less powering, and wireless data transfer.

These components form part of the CorTec Brain Interchange System for closed-loop applications. This implantable wireless system is designed to control as well online neurostimulation as prosthetic devices based on simultaneously recorded brain activity. The proprietary closed-loop software processes the recorded data and controls the application with unprecedented computational power that can easily be adapted to customer needs. In collaboration with partners and customers CorTec enables innovative therapies which truly adapt to the individual needs of the patient.

With the move, CorTec will lay the foundation for further development and continuous expansion of the company. Located at the heart of Freiburg, CorTec maintains its proximity to the Medical Center and the Department of Microsystems Engineering (IMTEK) of the University of Freiburg. The construction work of the new headquarters next to Freiburg Exhibition Center has already begun and is to be completed at the beginning of 2018.


Follow the construction progress live:


Download the Press Release: CorTec_PressRelease_02-2017



We invite you to check out the options of CorTec Brain Interchange technology for neurotherapeutic approaches either in the Central or in the Peripheral Nervous System. We are happy to discuss with you how we can support your research and development.

Meet us at booth No. 23 or in the scientific sessions!



Scientific Sessions & Poster Presentations


Listen to our CTO’s talk in the Stroke Rehabilitation Session:

  • Martin SchĂŒttler: ‘An Implantable Brain‐Computer Interface for Investigation of Closed‐Loop Therapies’

Tuesday 30 May, 16:40 – 16:50 at the Fintry Auditorium


Take a look at our Posters:

  • ‘Minimal-Traumatic Peripheral Nerve Cuff Electrodes’
  • ‘An Implantable Brain‐Computer Interface for Investigation of Closed‐Loop Therapies’

Tuesday 30 May, 16:30 – 18:20 at the Fintry Auditorium


Download the full Scientific Program



Dear Neurotech Community,

we are happy to announce that CorTec has decided to provide our Brain Interchange technology to support the development of new neurotheraputical applications. The development of new approaches in neurotherapy has increasingly taken up speed in the past 3 years. CorTec seizes the opportunity of this positive trend to partner up with industry and research.

“While CorTec alone could only focus on the development of one application, this way we can assist in the development of many applications”, comments founder and CEO Jörn Rickert on the company’s decision. With its high-channel recording and stimulation capability plus its customizable software that can run on powerful external devices, CorTec Brain Interchange is particularly suited for the emerging phase of researching how to read and write the language of the human brain.

From regaining movement control in paralysis to curing severe mental disorders to the treatment of diabetes or arthritis, researchers world-wide are making groundbreaking progress by communicating with the nervous system in its own language of tiny electrical impulses: Kristoffer Famm and his team at newly formed Galvani Bioelectronics, a joint venture between GlaxoSmithKline and Google’s Life Science Spin-off Verily, develop a whole range of novel treatments by stimulating specialized tiny nerves in the body.  Start-up companies like Synchronmed and G-Therapeutics develop innovative brain machine interfaces for prosthetics control. Also the established field of deep brain stimulation for treatment of Parkinson’s and other diseases is under refinement. “Closed-loop DBS is the logical future for brain neuromodulation.” states Kelly D. Foote, Co-Director of the University of Florida Movement Disorders Center in his paper on DBS for Tourette.

We are prepared to combine our technical and application expertise with the results of research to deliver the technology for new ways of therapy. Next to the closed-loop Brain Interchange system our °AirRayŸ electrode as well as our Hermetic encapsulation technology play an important role in the use of the system as a component. The ceramic Hermetic encapsulation protects the sensitive electronics of the implant from external influences. The flexible °AirRayŸ electrode technology allows stimulation and simultaneous recording of signals. Our Products and Know-How together build the interface to industry, researchers and clinics that combines biological understanding with technological specifications.

Following highest standards, all areas of work strictly comply with our certified quality management system according to DIN EN ISO 13485. All core manufacturing steps are carried out in our certified cleanrooms in-house.


Download the Newsletter:


Learn more about our Brain Interchange System

Want to join our team? Check out our vacancies

Take a look at all events

On the way to new personalized therapies for neurological diseases, CorTec is rearranging the structure of its advisory board. A new company advisory board has been created. Board members are Prof. Dr. Klaus Mangold, Dr. Hans Dietl and Bernhard Meder, three experienced advisors who will support the young medical engineering company located in Freiburg, Germany in its future development.

The two managing directors of CorTec, Dr. Jörn Rickert and Dr. Martin SchĂŒttler are delighted about the composition of the two advisory boards which are bolstering the company from now on: ” Prof. Dr. Klaus Mangold‘s international industry expertise, coupled with Bernhard Meder’s entrepreneurial competence and of Dr. Hans Dietl’s profound knowledge of the implant sector is a winning combination for us”, summarizes Dr. Martin SchĂŒttler.  “In addition to this entrepreneurial body, the Scientific and Technical Advisory Board with whom we are discussing the challenges of our product development is a wonderful extension,” adds Dr. Jörn Rickert.

Prof. Dr. Klaus Mangold takes over the chairmanship of the newly formed company advisory board. The Chairman of the Supervisory Board of TUI AG is also a member of supervisory and advisory boards of various international market-listed companies, including Continental AG (Hanover), Ernst & Young (London) and Alstom S.A. (Paris). As a serial entrepreneur, Bernhard Meder has set up several companies in the field of reed technology which he has led to worldwide success within the Meder electronic Group founded by him in 1986. As Chief Technology Officer of Otto Bock HealthCare GmbH, Dr. Hans Dietl has an outstanding experience in the implant business.

The advisory board advises and supervises the management of the company. The Scientific and Technical Advisory Board consists of professional from academia and industry  with technological and application expertise. Prof. Dr. Thomas Stieglitz (Laboratory of Biomedical Microtechnology, University of Freiburg), Prof. Dr. Ulf Ziemann (Medical Director Department of Neurology, University Hospital TĂŒbingen) and Alexander Mayr (Production Manager Med-El) will continue to support the development of CorTec’s Brain InterchangeÂź Technology and their potential applications.

Prof. Dr. Klaus Mangold describes the work in the new advisory board structure as extremely promising: “CorTec is a young company with great potential. As advisory board members, we support the technological development as well as the development of the company itself with the broad range of our expertise. We are looking forward to the growth of the company in the coming years, combined with the extension of its own cleanroom manufacturing facilities.”


Download the Press Release:


Learn more about our Advisory Board


Want to join our team? Check out our vacancies

Visit the MicroTEC SĂŒdwest Clusterconference and listen to a lecture  given by our CTO Dr. Martin SchĂŒttler about the next generation of neuroimplants. On Tuesday, 28th March 2017 he is speaking in panel “Smart Health” about opportunities in the development of new neuroimplants, from innovative biocompatible components to intelligent systems for neuromodulation.

Based on the AirRay¼ electrode technology CorTec develops electrode components of neuroimplants for different companies. Beyond that, CorTec is a specialist for ceramic encapsulation technology, which can be used to defend the implant’s electronics from the environment of the human body.

CorTec’s Brain Interchange combines all these components in one system. It can measure and analyze neuronal activity and can influence the nervous system with needs-oriented stimulation. The so called Closed-Loop function offers various scopes for individual and appropriated neurotherapy. The application of the system serves from controlling the assistance system of paralyzed patients to needs-based deep brain stimulation up to stroke rehabilitation or epilepsy intervention.

see the conference program

learn more about CorTec Business

An international team of researchers around CorTec’s long-standing cooperation partner Niels Bierbaumer, University of TĂŒbingen and Wyss Center Geneva, reported to be able to communicate with completely paralyzed persons in the so-called Complete Locked-In State who are suffering from amyotrophic lateral sclerosis.

Through a combined method using near-infrared spectroscopy together with electroencephalography (EEG) the researchers could overcome the limitations of the approaches tested so far. The patients were asked to answer general and also personal questions with either “yes” or “no”. The researchers determine the correct response rate with over 70%. A particularly surprising outcome of the study: The patients answered the question, if they were happy, repeatedly with “yes”.

The researchers regard their results as “a first step towards abolition of complete locked-in states, at least for ALS”.

Read the article

The first opportunity to get to know us and our products is coming up this year at MD&M in Anaheim from 7th to 0th of February.

We are presenting our products and services for industry customers at the biggest medical supply trade fair in North America: from custom-designed electrodes to hermetic encapsulations and interconnection technologies.

Visit us at booth no. 2898!

Learn more about MD&M West

Merry Christmas and a Happy New Year to all our customers, partners and friends!



Yesterday started the Innovation Cluster Inopro which is funded by the German Federal Ministry of Education and Research (Bundesministerium fĂŒr Bildung und Forschung, BMBF) within the program “Bringing Technology to the People” with an inaugural event in Berlin. In the course of the next five years CorTec is doing research on intelligent prostheses and orthoses together with a consortium of 11 partners from industry, clinics and research.

The program “Bringing Technology to the People” aims at enhancing the interaction of man and machine. Apart from other fields of use the BMBF especially wants to support the development of technologies which are easy to use and serve the real needs of the individual person.

„Interactive medical technologies help people after ill health, an accident or in the old age to live an active and self-determined life again. With all the desirable technical progress we have to take care, though, that especially in the medical field is connected to a high level of data security as well as to easy handling for people at any age”, says Federal Minister Johanna Wanka.

The Innovation Cluster Inopro is coordinated by Otto Bock Healthcare, one of the leading companies in the field of orthotics and prosthetics, and is focusing its research on intelligent prostheses and orthoses that can adjust actively to the needs of the person who is wearing them enabling an intuitive communication. One of the goals of the Cluster is to develop feeling prostheses which can sense touch and translate this into groping signals to the patient.

CorTec contributes with its Brain Interchange technology to the project which will be responsible to establish communication between nerves and orthoses or prostheses.

Learn more about the program “Bringing Technology to the People”

Learn more about CorTec Brain Interchange

November is a busy month for us! We are exhibting at the annual meeting of the Society for Neuroscience (SfN) in San Diego and in parallel at Compamed in Duesseldorf.

At the SfN meeting we are presenting our portfolio of products for neuroscientific research in the central and peripheral nervous system. Come and visit us at booth no. 632!

At Compamed we are focusing on our services for industry customers: the development and supply of implantable components of neuromodulation devices. Come and visit us at booth no. F19.2 in hall 8a!

Learn more about our products for research

Learn more about our products and services for industry

CorTec just closed a new investment that will support bringing new personalized therapies for neurological diseases to patients. With Mangold Invest a new investor could be attracted who wants to go along that way with the young medical engineering company located in Freiburg. Equally convinced of the success of this project are the previous investors who are participating in this round of financing.

The two managing directors of CorTec, Dr. Jörn Rickert und Dr. Martin SchĂŒttler consider the composition of the investment a piece of good fortune: “Finding a private investor with the treasure of experience and the international network just as Prof. Dr. Klaus Mangold who furthermore has a local connection to Freiburg is a highly rare coincidence”, comments Dr. Jörn Rickert. “The readiness of our previous investors to also participate in this investment underlines the potential of our technology in a strongly growing market as well as the quality of our work accomplished so far”, adds Dr. Martin SchĂŒttler.

CorTec’s Brain Interchange Technology is designed to enable new forms of therapies for neurological diseases as Parkinson’s, epilepsy or stroke. Unlike existing neurotherapy systems it can adjust its activities to the acute needs of the patient and combine a high effectiveness with a reduction of side effects. At the moment the implant system is in the last phase of pre-clinical testing. Afterwards it will be used in first clinical studies. CorTec is already active in the business of developing components for industry and research and is serving a growing circle of prestigious international customers. The company plans to expand the existing production facilities at a new location and also to increase the staffing.

The existence of the component business in combination with the development of innovative therapies was the clincher for Mangold Invest to participate in CorTec, explains Prof. Dr. Klaus Mangold: “At CorTec we found a young, talented and dynamic team which is about to take the leap from a university start-up to a highly innovative producing company. CorTec already has acquired significant public funding, especially from the German Federal Ministry of Education and Research (Bundesministerium fĂŒr Bildung und Forschung). This confirms not only the company’s innovative capacity, but also the social relevance of the Brain Interchange Technology. We are looking forward to accompanying the development of the company actively together with the other shareholders.”

The previous investors M-Invest, High-Tech GrĂŒnderfonds (HTGF) und LBBW Venture Capital who also participate in the investment take a similar view. Bernhard Meder, CEO at M-Invest, comments on the closing of the round of financing as representative of the participating investors: “We as the existing shareholders are happy to have found in Mangold Invest another supporter of the CorTec idea. Prof. Dr. Klaus Mangold and Dr. Christoph Mangold together with their team have a vast experience that will contribute to our success. We extend a warm welcome to them!”


Download the press release:


Learn more about our investors


This year’s Neural Interfaces Conference (NIC) takes place from the 25th to the 29th of June in Baltimore as a joint meeting together with the North American Neuromodulation Society (NANS).

The Neural Interfaces Conference has a long history of working on key problems for advancing neural prosthetics and interface technology. In the setting of the joint meeting with NANS the technical side encounters their counterparts from clinical practice and research.

CorTec is exhibiting during the four conference days at Sheraton Inner Harbor Hotel in the Severn Room at booth number 7.

Learn more about NANS-NIC

We are on our way to make our innovative technology the new gold standard of neurotherapy.

Come with us! We are looking for new team members to grow our departments development, manufacturing and marketing.

Learn more about all open positions

Who are the visionairies of today? What are the future scenarios that they are working at? Which attitudes can we find towards highly specialized high-tech research and its markets which is not only chaning our individual body, but also changes society? Where can be rooms opened for a public debate beyond vague hopes or fears? Which are the decision processes that we have to find to create future normalities?

Director Lukas Matthei is following these and other questions in his interactive project “Superkörper” (Super Bodies) at the Theater Freiburg in the time betwenn 15th and 23rd of April. CorTec is one of the visionary place where the research station will dock in the course of the project week.

Learn more (website in German):

Connecting the human brain to a computer is no longer science fiction. Patients unable to control their bodies will soon be able to control computers and external devices, like wheelchairs, using only mental processes, by means of a brain-computer interface.

Leigh Hochberg and our scientific partner Philipp Kellmeyer are talking at Harvard Medical School about the cutting edge of brain-computer interface technology, and to discuss the ethical and philosophical implications of research and clinical care using these technologies.


Not only over Bethlehem appeared a star in the sky…

Also we at CorTec are working with pleasure to brighten up your neural insights.


We wish all customers, partners and friends a shiny Merry Christmas and a brilliant new year!


The next event in the course of the Neuroethics Seminar series at Harvard Medical School will take place on Thursday, 3rd of December.

Topic of this edition are Brain-Computer-Interfaces (BCI) – also called Brain-Machine-Interfaces (BMI)  – that allow paralyzed persons to regain autonomy in daily routine by controlling wheel chairs or other assistive devices by the power of thougth.

The BMI researchers Leigh Hochberg from Harvard Medical School and Philipp Kellmeyer from the Medical Center, University of Freiburg, who is also one of the scientific collaboration partners of CorTec are discussing the latest results of their research and also ethical questions that are related to the use of such new technologies.

The lectures can be followed on live stream starting from 16.30h local time (22.30h MEZ). Thomas I. Cochrane is moderating the event.

Watch the event on Live-Stream

In the run-up to a talk that he will give next week in Boston Dr. Philipp Kellmeyer has given an interview to the web-portal about its research with Brain-Machine-Interfaces (BMI).

Dr. Kellmeyer is one of the scientific collaboration partners of CorTec at the Medical Center, University of Freiburg, with whom we are researching the practical use of our Brain Interchange technology that is supposed to give back some autonomy in daily routine.

On Thursday, 3rd of December, he will give a talk about new technological possibilities of BMIs and the ethical questions related to their application at the Center for Bioethics at Harvard Medical School.

Read the interview with Philipp Kellmeyer (in German)

Learn more about CorTec Brain Interchange

CorTec@SfN2015This year’s meeting of the Society for Neuroscience in Chicago goes on until Wednesday. Come and find us at booth number 1842!

We are exhibiting our complete product portfolio of electrodes for recording and stimulation in the Central and Peripheral Nervous System as well as our bi-directional implant system CorTec Brain Interchange.

Exhibition hours at McCormick Place are from 9.30 a.m. – 5 p.m.

Our latest news in October:

CorTec at SfN +++ New Product Presentation – New Marketing Campaign +++


CorTec at SfN

The 45th meeting of the Society for Neuroscience is approaching. From 17th to 21st October more than 30,000 neuroscientists from all over the world are coming together at McCormick Place in Chicago.

CorTec is presenting there our product portfolio for neuroscientific research: Neural interfaces for surface and depth recording and stimulation as well in the central as ins the peripheral nervous system.

Visit us at booth # 1842!


New Product Presentation – New Marketing CampaignCorTec_As_precious_as_your_research

Check out our website where we reworked the presentation of our products.
From now on you will find the technical specifications, our latest product catalogue for all our standard products listed in a separate area of our website.

We are also launching our new marketing campaign in the following days.

Visit our website to get a first impression.

A survey by order of the German Federal Ministry of Education and Research (Bundesministerium fĂŒr Bildung und Forschung, BMBF) shows simliar results to a recently published study in cooperation with the University Medical Center Freiburg: Innovative therapies like for example with neural implants enjoy broad acceptance among the German population.

A large marjority of respondents of the survey “Future Monitor – Thinking Health In a New Way” express a positive attitude towards new technologies in the field of medicine. This includes wearable (fitness wristbands or devices for measuring heart frequence, sleep patterns or the like), telemedicine or even neural implants. 51% of the interviewees could imagine to be treated with such implants, in the survey mainly referring to an improvement of memory capacity.

Learn more about the Study: Future Monitor – Thinking Health In A New Way

Dear customers and partners,

we are availabe for you also in the holiday period. You can reach us as usual from Monday to Friday from 9 to  17h.

As we are not fully staffed in the next weeks, please excuse, if some things should take a little bit longer.

We wish you a pleasant summer!

A recentyl published survey in the latest issue of Journal of Neural Engineering shows that the acceptance of implantable Brain Machine Interfaces (BMIs) by paralyzed patients is surprisingly high.

In the course of the survey 131 patients were interviewed who are affected by paralyses through ALS, stroke or spinal cord injury. The majority of the patients knew about the possibility to control assistive technology devices via BMIs and had a positive attitude toward invasive BMI approaches.

The study was conducted in a collaboration of University Medical Center Freiburg and CorTec.

Read the article

CorTec@INS2015-207x200Until thursday you can visit at the this year’s World Congress of the International Neuromodulation Society (INS) in MontrĂ©al.

You will find us at booth No. 21 at Fairmont Queen Elisabeth Hotel.

Learn more about 12th INS World Congress

Our latest news in July:

CorTec at INS World Congress in Montréal +++ Product Preview: Brain Interchange for Research +++


12th INS World Congress in Montréal, 06.-11.06.2015

The 12th world congress of the International Neuromodulation Society will be held from June 6th to 11th in Montréal, Canada.

The focus of this year’s INS meeting is on medicine evolving through technology. Especially in the field of Neuromodulation this combination creates new approaches that have a great transformative force on the treatment of a large number of diseases.

CorTec is presenting there our product portfolio for neuroscientific research. Please visit us at booth number 21.


Product Preview: Brain Interchange for Research

We provide first insights into our bi-directional implant system for closed-loop interactions with the brain: Brain InterchangeTM that is about to be launched shortly.

A powerful tool for Brain-Machine interactions, the system combines a number of unique features:BIC_ECoG-Cuff_XS

  • Fully implantability (no skin breaches, wireless transfer of power and data)
  • High channel count (32 channels for recoding, out of which 8 can also be used for stimulation)
  • Freely programmable closed-loop applications (control the system with your own computer, using our C++ programming interface)

While the CorTec Brain Interchange platform is being developed with long-term applications in clinical applications in mind, offering novel therapeutic options for neurological and psychiatric diseases, our first product release will be offered for preclinical research.

We are also happy to discuss possible use-cases with you. Please contact us via

Learn more about the CorTec Brain Interchange technology

Learn more about the technical specifications of CorTec Brain Interchange Research

Kuckucksuhr_963-01Another year is drawing to a close and we are taking a break until the 7th of January.

We are wishing all customers and partners a Merry Christmas and a good start into the new year!


Learn more about CorTec Brain Interchange

The World Federation of Neurology (WFN) proclaimed today to be the 1st World Brain Day. Thus, the association wants to emphasize the importance of prevention and also the necessity for ongoing research towards better treatment of neurological diseases. CorTec supports research and therapy in the neurological field with a new generation of technological devices.

The complexity of neurological diseases often distracts public awareness from the fact that brain diseases are the single most important cause of disability in the world. Especially diseases like stroke and dementia are increasing so fast that they will overextend the health care systems very soon.

Diseases affecting the brain include also Epilepsy, Depression, Tumors, Traumatic Injury, Alzheimer’s Disease or Chronic Pain. Prevention can help a lot. For the ones who become diseased a better treatment would be desirable which is why a lot of research has to be done in this field.

CorTec is offering innovative neurotechnological devices for research, diagnostics and therapy. Our °AirRay electrodes measure and stimulate neural activity either on the cortex or peripherally.

With CorTec Brain Interchange we a completely implantable closed-loop system for measuring and stimulating brain activity in long-term use. This highly efficient responsive system is a neurotechnological novelty, facilitating many innovative approaches in therapy and research.




More information on our Brain Interchange Technology:
CorTec Brain Interchange


More informations about our products:
Product Overview


More information on WFN’s World Brain Day initiative:

CorTec wishes a Mery Christmas and a Happy New 2014.